Replies to post #71347 on Biotech Values

[fudoo]

I expect they will try it in liver cancer with Nexavar.

There is a PEG-Interferon Alfa trial ongoing in liver cancer -

http://www.clinicaltrials.gov/ct2/show/NCT00375661?term=PEG-Interferon+Alfa-2b+liver+cancer&rank=4

and kidney cancer with Nexavar -

http://www.clinicaltrials.gov/ct2/show/NCT00589550?term=PEG-Interferon+Alfa-2b+kidney+cancer&rank=1

I am not knowledgeable about the differences in the interferons.

I have recently been diagnosed with liver cancer and intend to share my "findings" with the board if I live long enough to write a 1000 words.

[exwannabe]

Re: ZGEN's $287M for non HCV indications

What is the chance that this is really kind of BS? Presumably their is no cost to BMY for agreeing to this clause (assuming it is well defined). Yeh, if they want to run trials for cancer then a payment is possible, but perhapse they have 0 intent of ever doing such. Nobody will ever see the fine print.

Maybe a $1B deal just sounds cool. Gets the new management off to a flying start.

P.S., I am very long ZGEN so not bashing here.Just very much a cynic in Bioworld.